BREAST INFLAMMATORY CARCINOMA
Clinical trials for BREAST INFLAMMATORY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST INFLAMMATORY CARCINOMA trials appear
Sign up with your email to follow new studies for BREAST INFLAMMATORY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough breast cancer: immune therapy trial targets aggressive cases
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard hormone therapy helps prevent cancer from returning in patients with a specific, aggressive type of breast cancer. It is for people whose cancer did not completely disappear after initial chemotherap…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for aggressive breast cancer: drug boosts radiation power
Disease control OngoingThis study is testing whether adding a targeted drug called olaparib to standard radiation therapy works better than radiation alone for inflammatory breast cancer. It involves 300 patients who have already had surgery and chemotherapy. The goal is to see if this combination help…
Matched conditions: BREAST INFLAMMATORY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC